These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 804011)

  • 1. Amyloid fibril protein related to immunoglobulin lambda-chains.
    Skinner M; Benson MD; Cohen AS
    J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of human lambda light chain V/J/C segments: serologic analysis and primary structure of the lambda VI Bence Jones protein THO.
    Ghiso J; Solomon A; Frangione B
    J Immunol; 1986 Jan; 136(2):716-9. PubMed ID: 3079791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bence Jones protein and amyloid. Studies on the relationship between naturally occurring human anti-Bence Jones protein antibodies and Bence Jones protein with amyloid].
    Sellin D; Haferkamp O
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 147(3):173-89. PubMed ID: 4876308
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pattern of antibody structure. The amino acid sequence of a monoclonal immunoglobulin L-chain of lambde-type, subgroup I (Bence-Jones-protein Vor.). A contribution to the elucidation of the origin of antibody specificity (author's transl)].
    Engelhard M; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1975 Sep; 356(9):1413-44. PubMed ID: 809332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the light chain type of paraproteins, identification of heavy chain disease.
    Backhausz R; Lajos J
    Ann Immunol Hung; 1972; 16(0):43-50. PubMed ID: 4213025
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis.
    Terry WD; Page DL; Kimura S; Isobe T; Osserman EF; Glenner GG
    J Clin Invest; 1973 May; 52(5):1276-81. PubMed ID: 4700495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologically defined V region subgroups of human lambda light chains.
    Solomon A; Weiss DT
    J Immunol; 1987 Aug; 139(3):824-30. PubMed ID: 3110284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary amyloidosis and thrombophlebitis as complications of Bence-Jones plasmacytoma (lambda type)].
    Baier J; Neumann H; Grossmann R; Ricken D
    Med Klin (Munich); 1991 Jan; 86(1):53-7. PubMed ID: 1901936
    [No Abstract]   [Full Text] [Related]  

  • 12. N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V.
    Sletten K; Husby G; Natvig JB
    Scand J Immunol; 1974; 3(6):833-6. PubMed ID: 4218364
    [No Abstract]   [Full Text] [Related]  

  • 13. Double paraprotein aemias (IgMK plus IgGK and IgGK plus BJL).
    Péter K; Ottó S
    Ann Immunol Hung; 1972; 16(0):319-27. PubMed ID: 4213040
    [No Abstract]   [Full Text] [Related]  

  • 14. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
    Linke RP; Geisel O; Mann K
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amyloid fibrils. Biochemistry of proteins and precursor substances].
    Tawara S
    Nihon Rinsho; 1979 Sep; 37(9):3158-64. PubMed ID: 118276
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of amyloid.
    Glenner GG; Terry WD
    Annu Rev Med; 1974; 25():131-5. PubMed ID: 4132883
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins.
    White GC; Jacobson RJ; Binder RA; Linke RP; Glenner GG
    Blood; 1975 Nov; 46(5):713-22. PubMed ID: 809071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Bence jones protein (BJP) from a patient with primary amyloidosis identical to the amyloid fibril.
    Block PJ; Skinner M; Benson MD; Cohen AS
    Arthritis Rheum; 1975; 18(3):287. PubMed ID: 1137625
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (kappa) and lambda (lambda) antigenic determinants.
    Solomon A
    Scand J Immunol; 1976; 5(6-7):685-95. PubMed ID: 62385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.